[1] Abi KST, Habibian S, Salimi M, Shakeri A, Mojahed MM, Gharaati H. Tumor Control Probability (TCP) and Normal Tissue Complication Probability (NTCP) in Mono and Dual-isocentric Techniques of Breast Cancer Radiation Therapy. Archives of Breast Cancer. 2021:192-202. [DOI: 10.32768/ abc.202183192-202]
[2] Qi XS, White J, Li XA. Is α/β for breast cancer really low?. Radiother Oncol. 2011;100(2):282-8. [DOI: 10.1016/j.radonc. 2011.01.010] [PMID]
[3] PKazemzadeh A, Abedi I, Amouheidari A, Shirvany A. A radiobiological comparison of hypo-fractionation versus conventional fractionation for breast cancer 3D-conformal radiation therapy. Rep Pract Oncol Radiother. 2021;26(1):86-92. [DOI: 10.5603/RPOR.a2021.0015] [PMID] [PMCID]
[4] Budach W, Bölke E, Matuschek C. Hypofractionated radiotherapy as adjuvant treatment in early breast cancer. A review and meta-analysis of randomized controlled trials. Breast Care (Basel). 2015;10(4):240-5. [DOI: 10.1159/ 000439007] [PMID]
[5] Trialists' Group TS. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet. 2008;371(9618):1098-107. [DOI: 10.1016/S0140-6736(08)60348-7] [PMID] [PMCID]
[6] Xie Y, Bourgeois D, Guo B, Zhang R. Comparison of conventional and advanced radiotherapy techniques for left-sided breast cancer after breast conserving surgery. Med Dosim. 2020;45(4):e9-e16. [DOI: 10.1016/j.meddos.2020.05.004] [PMID]
[7] Li XA, Tai A, Arthur DW, Buchholz TA, Macdonald S, Marks LB, et al. Variability of target and normal structure delineation for breast cancer radiotherapy: an RTOG Multi-Institutional and Multiobserver Study. Int J Radiat Oncol Biol Phys. 2009;73(3):944-51. [doi: 10.1016/j.ijrobp.2008.10.034] [PMID] [PMCID]
[8] Haviland JS, Bentzen SM, Bliss JM, Yarnold JR, Group STM. Prolongation of overall treatment time as a cause of treatment failure in early breast cancer: An analysis of the UK START (Standardisation of Breast Radiotherapy) trials of radiotherapy fractionation. Radiother Oncol. 2016;121(3):420-423. [DOI: 10.1016/j.radonc.2016.08.027] [PMID]
[9] Petrova D, Smickovska S, Lazarevska E. Conformity index and homogeneity index of the postoperative whole breast radiotherapy. Open Access Maced J Med Sci. 2017;5(6):736-739. [DOI: 10.3889/oamjms.2017.161] [PMID]
[10] Petkovska S, Tolevska C, Kraleva S, Petreska E. Conformity index for brain cancer patients. 2010. [Link]
[11] Coles C, Brunt A, Wheatley D, Mukesh M, Yarnold J. Breast radiotherapy: less is more?. Clin Oncol (R Coll Radiol). 2013;25(2):127-34. [DOI: 10.1016/j.clon.2012.10.013] [PMID]
[12] Haviland JS, Owen JR, Dewar JA, Agrawal RK, Barrett J, Barrett-Lee PJ, et al. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol. 2008;9(4):331-41. [DOI: 10.1016/S1470-2045(08)70077-9] [PMID] [PMCID]
[13] Wang J, Li X, Deng Q, Xia B, Wu S, Liu J, et al. Postoperative radiotherapy following mastectomy for patients with left-sided breast cancer: A comparative dosimetric study. Med Dosim. 2015;40(3):190-4. [DOI: 10.1016/j.meddos.2014. 11.004] [PMID]
[14] Hosseini SM, Momennezhad M. [Dosimetric comparison of conventional and field-in-field techniques in early stage breast cancer radiotherapy (persian)]. Iranian Journal of Medical Physics. 2018;15:19-. [DOI: 10.22038/ijmp.2018.11864]
[15] Lee BM, Chang JS, Kim SY, Keum KC, Suh C-O, Kim YB. Hypofractionated radiotherapy dose scheme and application of new techniques are associated to a lower incidence of radiation pneumonitis in breast cancer patients. Front Oncol. 2020;10:124. [DOI: 10.3389/fonc.2020.00124] [PMID] [PMCID]
)